食道運動不良(IEM)治療の世界市場

• 英文タイトル:Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth

Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth「食道運動不良(IEM)治療の世界市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR2008050
• 出版社/出版日:Persistence Market Research / 2020年6月1日
• レポート形態:英文、PDF、302ページ
• 納品方法:Eメール
• 産業分類:生命科学
• 販売価格(消費税別)
  Individual User(1名用)¥534,100 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥828,400 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,155,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、食道運動不良(IEM)治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、価格分析、需要分析・予測、疾患別(嚥下障害、逆流性食道炎、灼熱痛、アカラシア)分析、エンドユーザー別(機関、小売り)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・市場状況
・価格分析
・需要分析・予測
・食道運動不良(IEM)治療の世界市場規模:疾患別(嚥下障害、逆流性食道炎、灼熱痛、アカラシア)
・食道運動不良(IEM)治療の世界市場規模:エンドユーザー別(機関、小売り)
・食道運動不良(IEM)治療の世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

The latest publication by Persistence Market Research (PMR) on the global ineffective esophageal motility treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global ineffective esophageal motility treatment market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the ineffective esophageal motility treatment market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the ineffective esophageal motility treatment market are presented in this comprehensive report, including year-on-year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers to know the demand for ineffective esophageal motility treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the ineffective esophageal motility treatment market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the ineffective esophageal motility treatment market. The insights and wisdom presented in PMR’s study can be leveraged by shareholders in the ineffective esophageal motility treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the Ineffective esophageal motility treatment market are also included in the current study. Depending on potential developments in the ineffective esophageal motility treatment market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this ineffective esophageal motility treatment market report, minor companies and new entrants can make suitable company choices to achieve traction in the ineffective esophageal motility treatment market.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Trends

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Outlook

4.1.3. Per Capita Healthcare Expenditure Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Change in Lifestyle & Growing Obesity Rate

4.2.2. Technological Advancements in Drug Development

4.2.3. Recent Product Launches

4.2.4. Increasing Incidence of Ineffective Esophageal Motility

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

4.4. Value Chain Analysis

5. Market Context

5.1. Product Adoption / Usage Analysis

5.2. Disease Epidemiology

5.3. Regulatory Scenario

5.4. Reimbursement Scenario

5.5. Key Strategies Followed By Manufacturers

6. Global Ineffective Esophageal Motility Treatment Market – Pricing Analysis

6.1. Regional Pricing Analysis Product

6.2. Global Average Pricing Analysis Benchmark

7. Global Ineffective Esophageal Motility Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) & Volume Units Analysis Product, 2015 – 2019

8.3. Current and Future Market Size (US$ Mn) & Volume Units Analysis and Forecast Product, 2020 – 2030

8.3.1. Devices

8.3.1.1. Reflux Management Systems

8.3.1.2. Endoscopic Pain Modulators

8.3.1.3. Endostaplers

8.3.1.4. Radiofrequency (RF) Ablation Devices

8.3.1.5. Myotomy Devices

8.3.2. Drugs

8.3.2.1. H2 Receptor Antagonist

8.3.2.2. Antacids

8.3.2.3. Proton Pump Inhibitors

8.3.2.4. Dopamine Antagonist

8.3.2.5. Prokinetic Agents

8.3.2.6. Calcium Channel Blockers

8.4. Market Attractiveness Analysis Product

9. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 – 2019

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 – 2030

9.3.1. Dysphagia

9.3.2. GERD

9.3.3. Burning chest pain

9.3.4. Achalasia

9.4. Market Attractiveness Analysis By Indication

10. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 – 2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 – 2030

10.3.1. Institutional sales

10.3.1.1. Hospitals

10.3.1.2. Ambulatory Surgical Centers

10.3.2. Retail Sales

10.3.2.1. Retail Pharmacies

10.3.2.2. Drug Stores

10.3.2.3. Mail order Pharmacies

10.4. Market Attractiveness Analysis By End User

11. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by Region

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019

11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. South Asia

11.3.5. East Asia

11.3.6. Oceania

11.3.7. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis By Region

12. North America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. Product

12.3.3. By Indication

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.5. Drivers and Restraints – Impact Analysis

13. Latin America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Rest of Latin America

13.3.2. Product

13.3.3. By Indication

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.5. Drivers and Restraints – Impact Analysis

14. Europe Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. Product

14.3.3. By Indication

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.5. Drivers and Restraints – Impact Analysis

15. South Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. Product

15.3.3. By Indication

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.5. Drivers and Restraints – Impact Analysis

16. East Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. Product

16.3.3. By Indication

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.5. Drivers and Restraints – Impact Analysis

17. Oceania Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. Product

17.3.3. By Indication

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.5. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Northern Africa

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. Product

18.3.3. By Indication

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.5. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis

19.2.1. China

19.2.2. India

19.2.3. Brazil

19.3. U.S. Ineffective Esophageal Motility Treatment Market Analysis

19.3.1. By Product

19.3.2. By Indication

19.3.3. By End User

19.4. Canada Ineffective Esophageal Motility Treatment Market Analysis

19.4.1. By Product

19.4.2. By Indication

19.4.3. By End User

19.5. Mexico Ineffective Esophageal Motility Treatment Market Analysis

19.5.1. By Product

19.5.2. By Indication

19.5.3. By End User

19.6. U.K. Ineffective Esophageal Motility Treatment Market Analysis

19.6.1. By Product

19.6.2. By Indication

19.6.3. By End User

19.7. Germany Ineffective Esophageal Motility Treatment Market Analysis

19.7.1. By Product

19.7.2. By Indication

19.7.3. By End User

19.8. France Ineffective Esophageal Motility Treatment Market Analysis

19.8.1. By Product

19.8.2. By Indication

19.8.3. By End User

19.9. Italy Ineffective Esophageal Motility Treatment Market Analysis

19.9.1. By Product

19.9.2. By Indication

19.9.3. By End User

19.10. Spain Ineffective Esophageal Motility Treatment Market Analysis

19.10.1. By Product

19.10.2. By Indication

19.10.3. By End User

19.11. BENELUX Ineffective Esophageal Motility Treatment Market Analysis

19.11.1. By Product

19.11.2. By Indication

19.11.3. By End User

19.12. Russia Ineffective Esophageal Motility Treatment Market Analysis

19.12.1. By Product

19.12.2. By Indication

19.12.3. By End User

19.13. Japan Ineffective Esophageal Motility Treatment Market Analysis

19.13.1. By Product

19.13.2. By Indication

19.13.3. By End User

19.14. South Korea Ineffective Esophageal Motility Treatment Market Analysis

19.14.1. By Product

19.14.2. By Indication

19.14.3. By End User

19.15. Australia Ineffective Esophageal Motility Treatment Market Analysis

19.15.1. By Product

19.15.2. By Indication

19.15.3. By End User

19.16. GCC Countries Ineffective Esophageal Motility Treatment Market Analysis

19.16.1. By Product

19.16.2. By Indication

19.16.3. By End User

19.17. South Africa Ineffective Esophageal Motility Treatment Market Analysis

19.17.1. By Product

19.17.2. By Indication

19.17.3. By End User

20. Market Structure Analysis

20.1. Market Structure Analysis by Tier of Companies

20.2. Market Share Analysis for Top Players

20.3. Market Presence Analysis

20.3.1. By Regional footprint of Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Johnson & Johnson

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Strategy Overview

21.3.2. Mylan Pharmaceutical

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Strategy Overview

21.3.3. MediGus Ltd.

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Strategy Overview

21.3.4. Torax Medical

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Strategy Overview

21.3.5. Medtronic plc.

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Strategy Overview

21.3.6. AstraZeneca plc.

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Strategy Overview

21.3.7. Teva Pharmaceutical Industries Ltd.

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Strategy Overview

21.3.8. Takeda Pharmaceutical Company Limited

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Strategy Overview

21.3.9. GlaxoSmithKline plc.

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Strategy Overview

21.3.10. Bayer AG

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Strategy Overview

21.3.11. Pfizer Inc.

21.3.11.1. Overview

21.3.11.2. Product Portfolio

21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Strategy Overview

21.3.12. Bausch Health Companies Inc.

21.3.12.1. Overview

21.3.12.2. Product Portfolio

21.3.12.3. Profitability by Market Segments (Product/Channel/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Strategy Overview

21.3.13. LABORIE

21.3.13.1. Overview

21.3.13.2. Product Portfolio

21.3.13.3. Profitability by Market Segments (Product/Channel/Region)

21.3.13.4. Sales Footprint

21.3.13.5. Strategy Overview

21.3.14. Mederi Therapeutics, Inc.

21.3.14.1. Overview

21.3.14.2. Product Portfolio

21.3.14.3. Profitability by Market Segments (Product/Channel/Region)

21.3.14.4. Sales Footprint

21.3.14.5. Strategy Overview

21.3.15. Becton, Dickinson and Company (C. R. Bard, Inc.)

21.3.15.1. Overview

21.3.15.2. Product Portfolio

21.3.15.3. Profitability by Market Segments (Product/Channel/Region)

21.3.15.4. Sales Footprint

21.3.15.5. Strategy Overview

21.3.16. EndoGastric Solutions, Inc

21.3.16.1. Overview

21.3.16.2. Product Portfolio

21.3.16.3. Profitability by Market Segments (Product/Channel/Region)

21.3.16.4. Sales Footprint

21.3.16.5. Strategy Overview

21.3.17. Olympus

21.3.17.1. Overview

21.3.17.2. Product Portfolio

21.3.17.3. Profitability by Market Segments (Product/Channel/Region)

21.3.17.4. Sales Footprint

21.3.17.5. Strategy Overview

21.3.18. Pentax

21.3.18.1. Overview

21.3.18.2. Product Portfolio

21.3.18.3. Profitability by Market Segments (Product/Channel/Region)

21.3.18.4. Sales Footprint

21.3.18.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables:

Table 01: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 02: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 03: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 04: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 05: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Region

Table 06: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 07: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 08: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 09: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 10: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 11: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 12: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 13: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 14: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 15: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 16: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 17: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 18: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 19: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 20: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 21: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 22: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 23: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 24: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 25: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 26: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 27: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 28: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 29: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 30: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 31: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 32: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 33: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 34: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 35: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 36: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 37: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 38: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 39: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 40: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 41: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 42: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 43: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 44: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 45: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 46: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 47: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 48: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 49: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 50: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 51: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 52: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User


• 英文レポート名:Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth
• 日本語訳:食道運動不良(IEM)治療の世界市場
• レポートコード:PMR2008050お問い合わせ(見積依頼・ご注文・質問)